Cilastatin

dipeptidase 1 ; Homo sapiens







29 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35108055 Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion. 2022 Feb 4 1
2 33513824 Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy. 2021 Jan 27 1
3 32373203 Organic anion transporters also mediate the drug-drug interaction between imipenem and cilastatin. 2020 Mar 2
4 31200653 Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties. 2019 Jun 14 1
5 26824987 Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer. 2016 Feb 23 2
6 25755052 In vitro characterization of the bioconversion of pomaglumetad methionil, a novel metabotropic glutamate 2/3 receptor agonist peptide prodrug. 2015 May 4
7 26504822 Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity. 2015 1
8 20435919 Cilastatin attenuates cisplatin-induced proximal tubular cell damage. 2010 Aug 1
9 9453453 Identification of urinary dipeptidase as the released form of renal dipeptidase. 1997 1
10 8776942 Recent advances in the chemistry and biology of carbapenem antibiotics. 1996 1
11 8899192 Nephroprotective effect of cilastatin in allogeneic bone marrow transplantation. Results from a retrospective analysis. 1996 Oct 1
12 7492120 The renal membrane dipeptidase (dehydropeptidase I) inhibitor, cilastatin, inhibits the bacterial metallo-beta-lactamase enzyme CphA. 1995 Jul 1
13 7648757 Meropenem clinical pharmacokinetics. 1995 Apr 3
14 2139939 [Clinical pharmacokinetics of an imipenem-cilastatin combination]. 1990 Apr 4 1
15 2768222 Purification and characterization of human microsomal dipeptidase. 1989 Jun 4
16 3331041 Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections. 1987 1
17 3480361 [Effects of cilastatin sodium, an inhibitor of dehydropeptidase-I, on human urinary peptide excretion. Patients with renal insufficiency]. 1987 Sep 1
18 3463788 [Imipenem/cilastatin sodium in the treatment of obstetric and gynecologic infections]. 1986 May 1
19 3465739 High-performance liquid chromatographic determination of cilastatin in biological fluids. 1986 Oct 31 1
20 3546249 An overview of the pharmacology of imipenem/cilastatin. 1986 Dec 1
21 3859242 Pharmacokinetics of imipenem-cilastatin in neonates. 1985 Apr 1
22 3863219 Pharmacokinetics of imipenem and cilastatin in volunteers. 1985 Jul-Aug 2
23 3863619 Cilastatin (MK 0791) is a potent and specific inhibitor of the renal leukotriene D4-dipeptidase. 1985 Sep 16 2
24 3867330 Cilastatin does not alter superoxide dismutase activity. 1985 Nov 1
25 3901213 Open trial of imipenem/cilastatin therapy for serious bacterial infections. 1985 Jul-Aug 1
26 3980311 Primaxin in the treatment of acute bacterial pneumonia in adults. 1985 Feb 2
27 6595962 Disposition of radiolabeled imipenem and cilastatin in normal human volunteers. 1984 Nov 1
28 6573157 Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors. 1983 Feb 1
29 6607914 In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria. 1983 Dec 4